Sweden · Delayed Price · Currency is SEK Inission AB Earnings Call Transcripts
Fiscal Year 2026
-
Q1 saw 37.4% sales growth and a 7% EBITDA margin, driven by acquisitions, cost-cutting, and strong demand in defense and data centers. Management expects to maintain current profit levels and sees guidance as conservative given the strong start.
Fiscal Year 2025
-
Q4 saw 23.7% sales growth and strong cash flow, with EBITDA up SEK 20.8 million year-over-year. Non-recurring financial costs from the AXXE acquisition impacted EPS, but leverage improved and a dividend is proposed. Outlook remains positive with achievable growth and margin targets.
-
Q3 saw 13.5% sales growth and improved EBITDA, driven by the Selteka acquisition and EMS strength, while Enedo continued restructuring with significant one-off costs. Break-even for Enedo is targeted for Q1 next year, and full recovery is expected as restructuring costs subside.
-
Q2 saw a 6.2% sales decline and lower EBITDA, but cost savings and a stable order book support optimism for H2 recovery. The Selteka acquisition and new facilities are expected to drive growth, while Enedo aims for break-even by year-end.
-
Turnover and EBITDA margins declined year-over-year due to lower sales and higher costs, but cost reduction programs are underway. The order book is up 23%, yet management remains cautious due to macro uncertainty and delayed deliveries. Acquisition capacity remains, and new production capabilities in Tunis are being developed.
-
Strong growth continues with a focus on acquisitions, organic expansion, and operational efficiency. Financial targets include 15% annual growth and 9% EBITDA margin mid-term, supported by a decentralized structure and investments in capacity. Defense and electrification trends offer new opportunities.
Fiscal Year 2024
-
Q4 saw a 4% sales decline and margin compression, but strong order intake and cash flow. Cost reductions continue, with further effects expected by Q2. 2025 guidance is conservative, targeting SEK 2.2 billion revenue and >6% EBITDA margin.
-
The company is navigating a challenging market with a focus on cost control, integration of recent acquisitions, and a revised financial outlook. Growth is expected to resume in H2 next year, with ongoing operational improvements and a strategic shift toward geographic expansion.
-
Q3 2024 saw a 9.1% sales decline and lower EBIT, prompting cost reductions and revised guidance. Order book duration normalized, and infrastructure demand is recovering, but market risks and cash flow pressures persist.
-
Q2 saw a slight sales increase but an organic decline, with EBITDA and margins down year-over-year. Cost-cutting and restructuring are underway to defend profitability, while new bank terms improve financing. Management remains committed to margin targets despite market headwinds.